Publications
- Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients2023 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients2020 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen
- ABC transporters are predictors of treatment failure in acute myeloid leukaemia2024 | First Faculty of Medicine, Faculty of Science
- Treatment of adult patients with acute lymphoblastic leukemia in the Czech Republic in the period 2007–20202023 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Novel Somatic UBA1 Variant in a Patient With VEXAS Syndrome2023 | First Faculty of Medicine
- Tyrosinkinázové inhibitory tří generací v léčbě akutní lymfoblastové leukemie dospělých2023 | First Faculty of Medicine
- Low levels of minimal residual disease after induction chemotherapy for BCR-ABL1-negative acute lymphoblastic leukaemia in adults are clinically relevant2022 | First Faculty of Medicine, Second Faculty of Medicine
- A validation study of potential prognostic DNA methylation biomarkers in patients with acute myeloid leukemia using a custom DNA methylation sequencing panel2022 | First Faculty of Medicine, Faculty of Science
- NPM1 and DNMT3A mutations are associated with distinct blast immunophenotype in acute myeloid leukemia2022 | First Faculty of Medicine
- Chimeric Antigen Receptor Based Cellular Therapy for Treatment Of T-Cell Malignancies2022 | First Faculty of Medicine
Loading network view...
